The therapeutic exploitation of IL-1 in cancer: Controlling tumor progression and resistance to targeted therapies
Fields of Study & Subjects
Immune Response and Inflammation
IL-33
ST2
and ILC Pathways
Inflammasome and immune disorders
Publication details
- Journal / source
- Seminars in Immunology
- Publisher
- Elsevier BV
- Volume
- 82
- Pages
- 102031–102031
- Publication date
- 15 May 2026
- Language
- EN